Our Capabilities
Purpose-Built Facilities and Experienced Teams
Wilmington PharmaTech delivers integrated small molecule API and HPAPI services designed to solve complex chemistry challenges and translate them into scalable, compliant manufacturing processes.
Our capabilities are intentionally connected. Chemistry decisions made early are informed by solid-state behavior, analytical strategy, and manufacturing realities. This integrated approach reduces downstream risk, shortens development cycles, and supports confident progression from discovery through commercial supply.
Our Founder, Hui-Yin Harry Li, Ph.D, describes Wilmington PharmaTech’s approach to successfully navigating complex programs
-
Discovery Chemistry
Early-stage chemistry sets the trajectory for the entire program. Wilmington PharmaTech’s discovery chemistry teams focus on translational problem-solving, addressing complexity early while keeping manufacturability and analytical requirements in mind.
From target synthesis and lead optimization to chiral challenges and early purification strategies, our work in discovery is designed to support efficient progression into development.
-
Solid State Chemistry
Solid-state behavior can determine whether a molecule succeeds or fails in development. Wilmington PharmaTech provides comprehensive solid-state chemistry expertise to identify optimal forms early and avoid late-stage surprises.
Our scientists apply systematic salt selection, polymorph screening, and crystallization optimization to support stability, bioavailability, and manufacturability.
-
Development Services
Wilmington PharmaTech’s development services bridge the gap between laboratory chemistry and commercial manufacturing. Our teams design, optimize, and scale processes with a focus on robustness, safety, and regulatory readiness.
We support API and HPAPI development through integrated process development, analytical method development, and IND-enabling services to prepare programs for clinical and commercial success.
-
GMP Manufacturing
Wilmington PharmaTech provides clinical and commercial GMP manufacturing for small molecules and HPAPIs within FDA-inspected US facilities.
Our manufacturing capabilities include dedicated HPAPI suites, kilo labs, and pilot scale infrastructure, supported by strong quality systems and experienced production teams focused on reliable execution.
-
Analytical Testing
Analytical science is embedded across Wilmington PharmaTech’s operations, supporting informed decision-making at every stage of development and manufacturing.
From in-process testing and release testing to full ICH stability programs and regulatory support, our analytical teams provide the data and insight needed to move programs forward with confidence.
SEND AN INQUIRY
We’re Ready to Start
Looking to connect? We welcome the opportunity to discuss your needs and questions.